Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

621 recalls · Class II, newest first

Class II · Moderate risk

Lacosamide Tablets

Presence of a Foreign Tablets: Complaint received, possible mix-up of Selexipag 1000 mcg tablet in a bottle of Lacosamide Tablets USP, 100mg.

Ongoing Particulate / foreign matter Annora Pharma Private Limited NDC 31722-813-60 D-0626-2026
Class II · Moderate risk

Budesonide Inhalation Suspension

Presence of Foreign Substance:This recall has been initiated in response to a product quality complaint reported for black/brown specs and particles within the ampoule solution

Ongoing Particulate / foreign matter Sun Pharmaceutical Industries INC NDC 47335-633-49 D-0607-2026
Class II · Moderate risk

TopCare health

Presence of foreign substance: small metallic particles in chewable tablets.

Ongoing Particulate / foreign matter Guardian Drug Co. Inc. NDC 76162-129-68 D-0579-2026
Class II · Moderate risk

TopCare health

Presence of foreign substance: small metallic particles in chewable tablets.

Ongoing Particulate / foreign matter Guardian Drug Co. Inc. NDC 76162-128-22 D-0578-2026
Class II · Moderate risk

HyVee

Presence of foreign substance: small metallic particles in chewable tablets.

Ongoing Particulate / foreign matter Guardian Drug Co. Inc. D-0572-2026
Class II · Moderate risk

HyVee

Presence of foreign substance: small metallic particles in chewable tablets.

Ongoing Particulate / foreign matter Guardian Drug Co. Inc. D-0571-2026
Class II · Moderate risk

Family Wellness

Presence of foreign substance: small metallic particles in chewable tablets.

Ongoing Particulate / foreign matter Guardian Drug Co. Inc. NDC 55319-171-68 D-0568-2026
Class II · Moderate risk

CAREone

Presence of foreign substance: small metallic particles in chewable tablets.

Ongoing Particulate / foreign matter Guardian Drug Co. Inc. NDC 72476-178-23 D-0566-2026

Recalls by year